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simply wrong.8 9 So differences in the correlations
between tests probably reflect content differences more
than different skills.
Current discussions about best evidence medical
education are an indication that, just as in clinical
medicine, intuitions will frequently be at variance with
evidence.10 And since we will continue to be engaged in
activities to ensure that our graduates are competent,
these procedures should be based on evidence of the
effectiveness of these methods. The ignorance of
relevant evidence is no more pardonable in education
than in clinical medicine.
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Falling neonatal autopsy rates
Neonatologists, pathologists, and relatives need to boost neonatal pathology
The provision of perinatal and paediatric patho›logy services is a sign of an enlightened society.It symbolises the care that society attaches to
the wellbeing of its young by trying to find out what
makes each pregnancy and infancy go well or badly.
Yet in their audit of neonatal autopsies in a tertiary
referral centre published in this week’s BMJ, Brodlie
and colleagues found a general fall in autopsy rates
over the past decade (p 761).1 This occurred despite a
senior clinician always asking relatives for permission
for autopsies and the availability of a dedicated paedi›
atric and perinatal autopsy service. What are we as cli›
nicians and as the lay public to make of this?
Geographical differences may exist in requests for
neonatal autopsies. Directors of British neonatal units
may have reservations about requesting an autopsy in
some cases,2 but Australian neonatologists do not seem
to share these.3 Nurses’ attitudes may differ from
doctors’.3 Grief counsellors, nurses, or social workers
who may be in contact with parents can unconsciously
send messages that discourage parents from consenting
to an autopsy. If, however, relatives are approached after
each neonatal death, as in Edinburgh, then we can
assume that failure to get permission is the limiting fac›
tor. When information on all aspects of the autopsy,
including its usefulness, is available to relatives when
consent is sought then it is their right to refuse permis›
sion. However, as caring professionals we need to
examine the reasons why this is happening.
It may be useful to involve a pathologist, preferably
the one doing the autopsy, while seeking consent.4 This
face to face meeting with the pathologist may clarify
some misunderstandings.5 The visibility of perinatal
pathologists while seeking consent may also help in
rehabilitating the subspecialty. The Alder Hey contro›
versy had the effect of demonising perinatal and
paediatric pathologists.6 Yet the core business of
perinatal and paediatric pathologists is to help women
and children. An acknowledgement in a scientific
paper expressing “appreciation to the many parents
who so generously gave permission to examine their
babies in the hope that some good might come of their
misfortune” suggests that pathologists are not
demons.7
Fetal and perinatal pathology is already a shortage
specialty in the United Kingdom. The reasons include
poor remuneration compared with general histo›
pathologists, and lower status.8 The tragic Alder Hey
controversy has only exacerbated this situation.9 Yet
this situation is not unique to Britain. Low recruitment
into the subspecialty, low budgets, and high workload
are problems in North America also.10
Perinatal pathology requires highly specialised diag›
nostic skills, and though based on morphological exam›
ination at autopsy, it is probably less confined than
general histopathology to morphology in reaching
clinicopathological correlations. Morphological descrip›
tion of abnormalities is only one skill. It is used to point
to additional investigations or to recall syndromes.
There is a greater need to integrate the results from
other laboratory disciplines with the obstetric and
neonatal history. Perinatal and paediatric pathologists
may require access to other perinatal and paediatric
clinical specialists to plan the autopsy or interpret the
findings. For example, many of the diagnoses with impli›
cations for future counselling in the report of Brodlie et
al would have depended on biochemical tests to confirm
the anatomical findings. In countries where autopsies
are publicly funded administrators need to recognise
that these laboratory tests can be expensive and that
correlating all the findings takes time.
Any parents who have lost an infant will want to ask
whether they get as excellent a service from their local
hospital as is available in Edinburgh. Studies have
shown that perinatal and paediatric autopsies are per›
formed best by perinatal and paediatric pathologists.11
In the United Kingdom the royal colleges of
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have made recommendations on interim and long
term provision of the service.8 Globalisation of knowl›
edge and technology has meant that many countries
now aspire to have neonatal intensive care units. Estab›
lished paediatric and perinatal pathologists have been
encouraged to participate in pathology congresses and
teaching programmes in developing countries to nur›
ture local expertise.12 But a real fear is that in future
there may be no experienced pathologist to do an
autopsy for those parents who want one.9
What can the lay public do about it? The findings
of Brodlie et al’s audit are of immediate relevance to
the relatives who want to know the cause of death, but
do not address the other benefits of autopsies. These
include auditing complications of care, providing
knowledge for research and teaching, and aiding grief
resolution. The public needs to ask if they wish to sup›
port these altruistic aims. Neonatologists and obstetri›
cians need to seek consent in every neonatal death or
stillbirth while pathologists need to provide the
service sought by clinicians and relatives. All need to
be vigilant about the quality and rates of perinatal
autopsies.11 13 If relatives wish to have these services
they might also have to demand adequate funding for
them.
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Protein conjugate pneumococcal vaccines
Offer new opportunities for high risk individuals but still lack robust evidence
Given the substantial global burden of invasivepneumococcal disease, the introduction ofprotein conjugate pneumococcal vaccines
may provide a useful option for protecting individuals
at risk. Optimism stems from a large prospective study
showing that a protein conjugate pneumococcal
vaccine prevented 94% of invasive disease in young
children.1 The clinical effectiveness of this vaccine now
needs to be established among other children and
adults at risk. These include people with increased
exposure to Streptococcus pneumoniae, immunological
defects due to HIV infection, bone marrow transplants,
multiple myeloma, nephrotic syndrome, anatomical or
functional asplenia, and older people with chronic
conditions. The efficacy of the vaccine is unpredictable
because the immune defects are different in each
group.
The need for a strict, objective assessment of the
vaccine is further enhanced by serious concerns raised
recently when this vaccine was unexpectedly found to
increase the rates of pneumonia in HIV infected indi›
viduals.2 The lack of knowledge of the basic mechanism
underlying pneumococcal vaccine failures indicates
that adequate evidence should be obtained, before
protein conjugate pneumococcal vaccines can be rou›
tinely recommended for people at greatest risk.
Early reports for improved protein conjugate
pneumococcal vaccine immunogenicity among differ›
ent target groups3–5 have limitations in predicting clini›
cal efficacy. Immunogenicity does not necessarily imply
opsonising antibody production. One study showed
that the ineffectiveness of pneumococcal polysaccha›
ride vaccine among the elderly was due to the poor
production of opsonising antibodies after vaccination
regardless of antibody titres achieved.6 The protein
conjugate pneumococcal vaccine could be a better vac›
cine if it could induce functionally improved immune
responses. Among healthy individuals this vaccine
induces a 16›300 fold increase in serum opsonophago›
cytic activity compared to a threefold increase induced
by pneumococcal polysaccharide vaccine.7 Immuno›
logical memory also needs to be considered, since it
may correlate with subsequent protection, even in the
face of suboptimal vaccine immunogenicity. Indirect
evidence for the fundamental role of memory in dura›
ble protection comes from our experience with the
epidemiological impact of Haemophilus influenzae type
b (Hib) vaccines. While the plain polysaccharide
vaccine had no epidemiological impact, the incidence
of Hib disease declined rapidly after the introduction
of conjugate vaccines, and even the least immunogenic
conjugate vaccines were effective.8 9
The superiority of protein conjugate pneumococ›
cal vaccine induced immune responses is promising,
but does not guarantee clinical efficacy. Prospective
randomised controlled trials are indispensable. Both
clinical and bacteriological outcomes should be used,
acknowledging the unavoidable limitations of each
endpoint. Clinical outcomes may be less specific, while
bacteriological outcomes may be less sensitive in
healthcare settings where few cultures are drawn or
antibiotics are given before cultures are obtained. Fur›
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